Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Bioorg Med Chem Lett. 2009 Mar 14;19(9):2509–2513. doi: 10.1016/j.bmcl.2009.03.030

Table 2.

The Ki values for the inhibition of purified recombinant human MAO by isatin (1) and (E)-styrylisatin analogues (45)

MAO-A wild- typea (μM) MAO-B wild-typeb (μM) MAO-B selectivityc MAO-B I199A mutanta (μM)
1 Isatin 15d 3d 5.0 12 ± 2
4a (E)-5-Styrylisatin 0.78 ± 0.10 0.31 ± 0.06 2.5 1.1 ± 0.2
4b (E)-5-(3-Chlorostyryl)isatin 5.6 ± 0.3 1.4 ± 0.4 4.0 12.5 ± 0.7
4c (E)-5-(3-Fluorostyryl)isatin 2.2 ± 0.2 0.60 ± 0.07 3.6 4.5 ± 0.2
5 (E)-6-Styrylisatin 22 ± 2 0.56 ± 0.02 39 2.2 ± 0.4
a

The Ki values were determined spectrophotometrically using p-CF3-benzylamine as substrate.

b

The Ki values were determined spectrophotometrically using benzylamine as substrate.

c

Selectivity for the B isoform is given as the ratio of Ki(MAO-A) to Ki(MAO-B) of the wild-type enzymes.

d

Values obtained from reference.9